Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-1/A Apr 8, 2020 S-1/A
S-1/A Apr 3, 2020 S-1/A
DRS Apr 1, 2020
8-K Mar 30, 2020 8-K
CORRESP Feb 28, 2020
S-1/A Feb 28, 2020 S-1/A
SEC STAFF LETTER Feb 28, 2020
S-8 Feb 26, 2020 S-8
3 Feb 19, 2020 FORM 3 SUBMISSION
8-K Feb 19, 2020 8-K
SC 13G/A Feb 14, 2020
SC 13G/A Feb 14, 2020 AMENDMENT NO. 1
10-Q Feb 14, 2020 10-Q
8-K Feb 14, 2020 8-K
SC 13G/A Feb 12, 2020
SC 13G/A Feb 12, 2020 IMMUNOVANT, INC.
SEC STAFF LETTER Feb 6, 2020
UPLOAD Jan 30, 2020
S-1 Jan 17, 2020 FORM S-1
SC 13D Dec 27, 2019 SCHEDULE 13D
4 Dec 20, 2019 4
3 Dec 20, 2019 3
SC 13D Dec 20, 2019 SC 13D
8-K Dec 20, 2019 8-K
4 Dec 20, 2019 FORM 4 SUBMISSION
← Newer Page 22 of 26 · 646 filings Older →